Dr. Homayoon Khanlou, MD

Dr. Khanlou practices at American Family Care Agoura Hills in Agoura Hills, California.

Dr. Khanlou's NPI, 1356335277, was assigned on September 7, 2005. Dr. Khanlou graduated from Paris Descartes University Faculty of Medical Science in 1995. Dr. Khanlou holds California license A66631.

Dr. Khanlou's primary practice is American Family Care Agoura Hills, at 5825 Kanan Rd, Agoura Hills, CA 91301. The practice phone is (424) 355-1963.

Dr. Khanlou's primary practice is American Family Care Agoura Hills in Agoura Hills, California. The medical group on file is AFC Urgent Care Agoura Hills. Dmand AI also links Dr. Khanlou to 3 more home health agencies, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khanlou practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Khanlou's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Khanlou is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Khanlou's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists acute sinusitis, acute skin infection, ankle or foot injury, asthma, broken or dislocated ankle/ or foot, bronchitis, bursitis and chest wall injury among the conditions Dr. Khanlou treats.

CMS data shows 2,312 Medicare services from Dr. Khanlou across 19 procedure codes in 2024, for 560 Medicare patients. Medicare paid $97,328 for them. Every service was in an office.

CMS counts 560 Medicare patients who saw Dr. Khanlou in 2024. The largest group is 65 to 74, with 278 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Khanlou's median patient age at 47, with 56% women.

In 2024, Dr. Khanlou wrote 1,938 Medicare Part D claims for 683 patients. 86% of them were for generic drugs. CMS names the drug for 1,584 of them, across 39 drugs with 11 or more claims each, at $104,992 in total drug cost. In 2023, CMS named 1,455 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Khanlou for performance year 2024, reported individually. Dr. Khanlou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khanlou as offering telehealth.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Khanlou, published from 2010 to 2014. Dr. Khanlou's most frequent co-authors are Timothy Wayne Fong, MD, Theodoros Kelesidis, MD and Iman Parhami, MD, MPH.

Dmand AI links Dr. Khanlou to 1 clinical trial. Conditions studied include Acquired Immunodeficiency Syndrome and Slow Virus Diseases.

CMS Open Payments shows 26 general payments to Dr. Khanlou from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Amgen Inc. paid the most, $86.

Dr. Khanlou graduated from Paris Descartes University Faculty of Medical Science in 1995.

Dr. Khanlou is in network with 7 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.